Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Access to medicines and treatment news

Show

From To
Chinese study sheds light on how well treatment may work as prevention in the real world

A study from the Henan province of China published recently shows that antiretroviral therapy (ART) may not be as effective at suppressing HIV and preventing onward transmission

Published
12 hours ago
By
Gus Cairns
MSM and transgender people are absent from the Global Fund country dialogue in Eastern Europe and Central Asia

Men who have sex with men (MSM) and transgender people (TG) are not involved in strategic discussions around HIV in most nations of Eastern Europe and Central Asia (EECA). Lack of reliable epidemiological data, high stigma, and policies that restrict the access of MSM and TG to information on HIV preclude the two key populations from meaningfully participating in the country dialogue processes.

Published
14 hours ago
From
EATG
Aetna to Lower Costs for Most HIV Drugs After Complaint

Aetna Inc. has agreed to reduce out-of-pocket payments for most HIV and AIDS medicines after pressure from an advocacy group, revising coverage that had some patients paying $1,000 a month for the drugs.

Published
30 March 2015
From
Bloomberg
Most HIV-positive gay men in European survey are on HIV treatment, though fewer in the east

The large EMIS survey of gay men living in Europe has found that over 70% of respondents with HIV are taking antiretroviral therapy (ART). Of those who

Published
30 March 2015
By
Gus Cairns
Guidance on overseas visitors hospital charging regulations

Guidance for NHS bodies in carrying out their duties under the NHS (Charges to Overseas Visitors) Regulations 2015 to make and recover charges for NHS hospital treatment from chargeable overseas visitors. It also includes guidance to safeguard the health of those not entitled to free hospital treatment and new guidance on sharing information on NHS debtors to subject them to immigration sanctions.

Published
27 March 2015
From
Department of Health
UNAIDS holds virtual consultation for its 2016–2021 Strategy

UNAIDS is holding its first round of virtual consultations to develop its 2016–2021 Strategy. From 23 March to 2 April, the consultation process will be open to everyone to share information, ideas and experiences on how to accelerate rights-based, evidence-informed action to Fast-Track the AIDS response.

Published
26 March 2015
From
UNAIDS
KEI Europe asks Romanian government to issue compulsory licences on hepatitis C medicines

For a country with a gross national income (GNI) per capita of $9,060, roughly one-quarter of the overall GNI per capita across the EU, the medicines are simply too costly to be within reach of patients in need, and put strains on the government's ability to provide reimbursements.

Published
23 March 2015
From
Knowledge Ecology International
Indian generic companies should reject Gilead’s controversial hepatitis C ‘Anti-Diversion’ programme

Ahead of a meeting in Jaipur, India next week between US pharmaceutical company Gilead Sciences and several Indian companies which have entered into an agreement with Gilead to produce hepatitis C drugs, Médecins Sans Frontières/Doctors Without Borders (MSF) urged the generic companies to reject a highly-controversial programme that could compromise people’s treatment and confidentiality.

Published
19 March 2015
From
MSF
Gilead to require proof of citizenship to buy Sovaldi in poor countries

Médecins Sans Frontières/Doctors Without Borders (MSF) is urging Gilead to drop some of the provisions. If Gilead won't, MSF suggests that generic drugmakers ignore some of the requirements, like demanding that patients provide proof of citizenship to fill a prescription.

Published
19 March 2015
From
Fierce Pharma
$10 Copy of Gilead Blockbuster Sovaldi Appears in Bangladesh

Incepta Pharmaceuticals Ltd. doesn’t have a license from Gilead and its version was launched last month, said Managing Director Abdul Muktadir. The company also aims to sell the drug overseas, including to parts of Southeast Asia and Africa.

Published
09 March 2015
From
Bloomberg
← First12345...88Next →

Filter by country